Aprepitant Impurity D-13C2,d2 | 
    |
| Synonyms: 2-(R)-[1-(R)-(3,5-Bis(trifluoromethyl)phenyl)ethoxy]-3-(S)-fluorophenyl-4-[(2-N-methoxycarbonyl)acetamidrazono]morpholine-13C2,d2 | |
| Cat. No.: A66264 | CAS No.: Unlabelled: 219821-37-1 | 
| MDL.: | Formula: C2213C2H23D2F7N4O4 | 
| F.W.570.47 | Purity: 99% | 
| Storage: No Data Available | |
|   | |
             | Catalog Number: | A66264 | CAS No.: | Unlabelled: 219821-37-1 | |
| MDL: | Formula: | C2213C2H23D2F7N4O4 | ||
| F.W.: | 570.47 | Purity: | 99% | |
| Package: | Unit: | mg | ||
| Appearance: | Pale-Yellow Solid | M.P.: | No Data Available | |
| B.P.: | Density: | |||
| Optical Rotation: | Refractive Index: | |||
| Solubility: | Stability: | Chloroform, Dichloromethane, Methanol | ||
| Storage: | No Data Available | Category: | Reference Standard | |
| Reference: | Ballard, T., et al.: Eur. J. Pharmacol., 412, 255 (2001), Campos, D., et al.: J. Clin. Oncol., 19, 1759 (2001), Severini, C., et al.: Pharmacol. Rev., 54, 285 (2002) | |||
| Application: | Labelled Aprepitant derivative. | |||
| Category: | Isotope Labelled Compounds, Pharmaceuticals, Intermediates & Fine Chemicals, | |||








